Psoriasis: Live Clear. Live Free.

Of all autoimmune diseases, psoriasis is the most common with nearly 7.5 million Americans affected. Studies indicate that psoriasis does not discriminate between
males and females afflicting both at about the same rate. Caucasians, however, develop psoriasis more frequently than other races.

Psoriasis is a chronic disease with no known cure but it can be put into prolonged remission with treatments that manage its symptoms and clear its visible
signs. And one of the most effective is the XTRAC® light treatment, the only FDA-cleared excimer laser clinically proven to slow and reverse the growth of
psoriatic cells. Unlike conventional light therapies, the XTRAC excimer laser delivers a highly targeted therapeutic beam of UVB light to areas of the skin affected by
psoriasis without harming the surrounding skin so you can LIVE CLEAR. LIVE FREE.

Psoriasis is a complex disease and while its precise cause is not fully understood, scientists know that the immune system and genes play key roles in its development. Researchers studying the immune system have learned that T cells* mistakenly trigger a reaction in the skin cells. The reaction activates a cascade of events, causing new skin cells to surface in days rather than weeks and accumulate on the skin’s surface. The reason T cells trigger this reaction seems to lie in cell DNA and inherited genes.
And, while scientists are still trying to identify all of the genes involved, they have discovered that one which regulates how the immune system fights infection is involved.
Scientists have also learned that not everyone who inherits genes for psoriasis develops it. For psoriasis to appear, it seems that a person must inherit the “right”
mix of genes and be exposed to a trigger, commonly stress, a skin injury or a strep (throat) infection. Triggers, however, are not universal and what triggers psoriasis in one person may not cause it to develop in another. Psoriasis is an unpredictable disease. It may be limited to a few lesions or may involve moderate to large areas of skin. When less than 3% of the body is affected by psoriasis, it is considered mild; 3 to 10% of the body psoriasis is considered moderate and more than 10% is considered severe.
( For most individuals, the palm of the hand is about the same as 1% of the skin surface.)

 

For more see, clinicals